Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Financials of Foseco India Ltd
Quarter-by-quarter operating performance
| Dec 2024 | Mar 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Sales + | 136 | 149 | 151 | 189 | 202 |
| Expenses + | 114 | 121 | 123 | 147 | 161 |
| Operating Profit | 23 | 27 | 28 | 42 | 41 |
| OPM % | 17% | 18% | 18% | 22% | 20% |
| Other Income + | 6 | 4 | -1 | -12 | 11 |
| Interest | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 3 | 2 | 3 | 6 | 8 |
| Profit before tax | 26 | 29 | 24 | 24 | 44 |
| Tax % | 26% | 26% | 31% | 36% | 23% |
| Net Profit + | 20 | 22 | 16 | 15 | 33 |
| EPS in Rs | 30.61 | 33.93 | 25.82 | 16.72 | 44.86 |
Financials of Foseco India Ltd
Annual income statement trend
| Dec 2024 | Dec 2025 | |
|---|---|---|
| Sales + | 525 | 643 |
| Expenses + | 434 | 519 |
| Operating Profit | 91 | 125 |
| OPM % | 17% | 19% |
| Other Income + | 18 | -5 |
| Interest | 0 | 0 |
| Depreciation | 10 | 13 |
| Profit before tax | 98 | 106 |
| Tax % | 26% | 29% |
| Net Profit + | 73 | 75 |
| EPS in Rs | 114.35 | 95.91 |
| Dividend Payout % | 22% | 26% |
Financials of Foseco India Ltd
Capital structure and asset base
| Dec 2024 | Dec 2025 | |
|---|---|---|
| Equity Capital | 6 | 8 |
| Reserves | 337 | 1,029 |
| Borrowings + | 2 | 3 |
| Other Liabilities + | 139 | 329 |
| Total Liabilities | 484 | 1,368 |
| Fixed Assets + | 45 | 774 |
| CWIP | 2 | 4 |
| Investments | -0 | -0 |
| Other Assets + | 438 | 590 |
| Total Assets | 484 | 1,368 |
Financials of Foseco India Ltd
Operating, investing and financing cash movement
| Dec 2024 | Dec 2025 | |
|---|---|---|
| Cash from Operating Activity + | 42 | 98 |
| Cash from Investing Activity + | -143 | -75 |
| Cash from Financing Activity + | -16 | -17 |
| Net Cash Flow | -117 | 6 |
| Free Cash Flow | 27 | 89 |
| CFO/OP | 76% | 105% |
Financials of Foseco India Ltd
Working capital efficiency and return ratios
| Dec 2024 | Dec 2025 | |
|---|---|---|
| Debtor Days | 85 | 87 |
| Inventory Days | 47 | 57 |
| Days Payable | 155 | 166 |
| Cash Conversion Cycle | -22 | -22 |
| Working Capital Days | 24 | 19 |
| ROCE % | 17% |
EBITDA margin improvement potential in explosive business to reach mid-teens (18-19% global benchmarks), with combined Solar-BME margins currently at 13-14%…
The net debt has already been reduced significantly from Rs.922 Crores at acquisition to Rs.531 Crores. Key concall takeaways from Sudarshan Chemical…
250-260 crores in FY27 with about 20% EBITDA margin, growing at 11-12% annually in absolute terms. Key concall takeaways from Indo Borax & Chemicals Ltd's Q1…
Chemicals business is guided for 15-20% growth in FY27, with a strong Q1 performance positioning the company to possibly hit the higher end of this range (Page…